ClinicalTrials.gg
Not yet recruitingNCT07836491SHUTi-DCUpdated Sep 23, 2026

Web-Based Insomnia Treatment for Spousal Dementia Caregivers (SHUTi-DC)

An interventional study of SHUTi-DC and PE in Insomnia, sponsored by University of Missouri-Columbia. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-23.

Sponsored by University of Missouri-Columbia · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 18 studies in Sleep Initiation and Maintenance Disorders by University of Missouri-Columbia — 4 open to participants now, 5 under way, none of them phase 3. Sleep Initiation and Maintenance Disorders · University of Missouri-Columbia.

Planned enrollment
6th of 18
80 · median 59
Started
2027
the only one that year
No phase
18 of 18
4 open now
Registered
18th of 18
by date

Among the 18 studies in Sleep Initiation and Maintenance Disorders by University of Missouri-Columbia, this one is the 6th largest by planned enrollment, is the only one that started in 2027, is one of 18 with no phase, and was the 18th registered.

Sleep Initiation and Maintenance Disorders

2,722 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 726 are open to participants now.

Browse Sleep Initiation and Maintenance Disorders studies →

Open to participants now

4 of the 18 studies in Sleep Initiation and Maintenance Disorders by University of Missouri-Columbia are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 386 Sleep Initiation and Maintenance Disorders studies recruiting now, 152 (39%) set no upper age limit and 204 (53%) stop at 75 or younger; 59 take children under 18; 108 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Sleep Initiation and Maintenance Disorders by University of Missouri-Columbia, or all of them as a file.
02

Study summary

Many people who care for a husband or wife with Alzheimer's disease or another dementia have trouble sleeping. About 40 to 60 out of every 100 spousal caregivers have insomnia, which means trouble falling asleep, trouble staying asleep, or waking up too early. Poor sleep can make it harder to handle stress, think clearly, and stay healthy.

Cognitive behavioral therapy for insomnia, or CBT-I, is the recommended treatment for insomnia. It helps people change the habits and thoughts that keep them awake. But CBT-I is hard for caregivers to get. There are not enough trained therapists, and caregivers often cannot leave home for appointments.

This study tests an online program called SHUTi-DC. It delivers CBT-I over the internet, so caregivers can use it at home whenever it fits their schedule. The program was adapted for people caring for a spouse with dementia.

The study will enroll 80 spousal caregivers who have insomnia symptoms. Half will be assigned to SHUTi-DC, which has eight weekly online modules that take 20 to 40 minutes each. The other half will receive a web-based sleep education program with general information about sleep health. A computer decides which program each person receives, similar to flipping a coin.

Everyone will answer questions about their sleep and well-being at the start of the study, each week during the program, and again six weeks after the program ends.

The researchers want to find out whether SHUTi-DC improves insomnia symptoms, how it works, and whether caregivers find the program helpful and easy to use.

03

Conditions studied

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • Spousal caregiver of a person with a clinician-diagnosed Alzheimer's disease or related dementia, with both partners cohabiting in the community
  • insomnia symptoms, defined as an Insomnia Severity Index (ISI) score of 8 or higher
  • Regular internet access and ability to independently use a computer or smartphone
  • Fluent in English
  • Residing within the United States

Exclusion criteria

Exclusion Criteria:

  • Parasomnia symptoms, including dream enactment or injurious nocturnal behaviors suggestive of REM sleep behavior disorder
  • Night-shift work, indicating primary circadian misalignment rather than insomnia
  • Current behavioral or psychological treatment for insomnia
  • Severe psychiatric conditions, such as current mania or hypomania, that would interfere with participation or safety
  • Significant cognitive impairment in the caregiver that would limit ability to engage in study procedures
  • Medical conditions that substantially affect sleep or safety, including neurodegenerative disease, stroke, traumatic brain injury, epilepsy, severe respiratory disease, pregnancy, or breastfeeding
  • Sleep difficulties fully attributable to caregiving tasks without underlying insomnia mechanisms
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    SHUTi-DC

    Participants receive SHUTi-DC, an adapted version of the Sleep Healthy Using the Internet program consisting of eight weekly interactive online modules: six standard cognitive behavioral therapy for insomnia modules plus two dementia-specific modules. Each module takes 20 to 40 minutes.

    Behavioral: SHUTi-DC

  • Active comparator
    Patient Education (PE)

    Online sleep health education delivered as static text-based content in a single release, plus two adapted modules addressing the dementia caregiving context.

    Behavioral: PE

Interventions

  • BehavioralSHUTi-DC

    An adapted, self-paced, web-based cognitive behavioral therapy for insomnia program for spousal ADRD caregivers. The program includes eight modules: six standard SHUTi CBT-I modules covering sleep restriction, stimulus control, cognitive restructuring, sleep hygiene, and relapse prevention, plus two psychoeducational modules with dementia-specific content addressing dementia education, disease progression, caregiving routines, and heightened vigilance. Modules are asynchronous and completed over an eight-week period, with each 20 to 40 minute session unlocking weekly to encourage metered participation. Participants complete daily online sleep diaries that generate tailored sleep schedule recommendations.

    Also known as: Sleep Healthy Using the Internet for Dementia Caregivers

  • BehavioralPE

    An active control condition providing online sleep health information. Materials cover content similar to SHUTi, including insomnia prevalence and causes and basic strategies to reduce insomnia symptoms, but are simpler and primarily text-based and no interactive or video-based elements. All content is delivered at once rather than unlocking weekly. Participants also receive the adapted portions of Module 1 and Module 8 containing dementia-specific content tailored for spousal ADRD caregivers.

    Also known as: Patient Education

06

What researchers measure

Primary outcomes

  1. Change in Insomnia Severity Index (ISI) score

    The Insomnia Severity Index assesses the nature, severity, and impact of insomnia. Scores of 8 or above indicate clinically significant insomnia symptoms.

    Time frame: Baseline, weekly during the intervention period, and at a post-intervention follow-up conducted 6 weeks after the intervention ends

Secondary outcomes

  1. Change in sleep efficiency

    Sleep efficiency is derived from the 11-item Consensus Sleep Diary, completed daily by participants in both conditions throughout the intervention period.

    Time frame: During the 8-week intervention period

  2. Change in Pre-Sleep Arousal Scale (PSAS) score

    The Pre-Sleep Arousal Scale is a 16-item self-report measure of cognitive and somatic arousal at bedtime, completed by participants in both conditions.

    Time frame: During the 8-week intervention period

Other outcomes

  1. Change in midsleep timing regularity

    Midsleep timing regularity is calculated as the standard deviation of midsleep time derived from the 11-item Consensus Sleep Diary, completed daily by participants in both conditions throughout the intervention period.

    Time frame: During the 8-week intervention period

  2. Change in Dysfunctional Beliefs and Attitudes about Sleep-16 (DBAS-16) Score

    The DBAS-16 is a 16-item self-report measure of sleep-related beliefs and attitudes, completed by participants in both conditions.

    Time frame: During the 8-week intervention period

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data underlying published results will be made available to qualified researchers. The dataset will include demographic and clinical characteristics, daily sleep diary data, weekly survey data, and outcome measures, together with a data dictionary. Direct identifiers will be removed and indirect identifiers will be modified or aggregated as needed to protect participant confidentiality, consistent with the informed consent under which data were collected.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code

Time frame: Beginning at the time of publication of the primary results. Data will remain available for at least 5 years thereafter.

Access criteria: Qualified researchers with an academic or institutional affiliation may request access. Requests must include a methodologically sound research proposal describing the planned analyses and a signed data use agreement. Requests will be reviewed by the study principal investigator, with input from co-investigators as needed. Approved requesters will receive a de-identified dataset with an accompanying data dictionary, along with the study protocol and statistical analysis plan, transferred through a secure institutional file transfer service. Data may be used only for the purposes described in the approved proposal and may not be redistributed to third parties.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Feb 2028, 13 months later.

Of 1,207 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's planned 13 months is below that.

Counting every sponsor, half of 1,285 studies reached it within 15 months; a quarter within 6 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 17, 2026
First posted
Sep 23, 2026
StartEst.
Jan 1, 2027
Primary completionEst.
Feb 28, 2028
CompletionEst.
May 31, 2028
Last update
Sep 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07836491
Responsible party
Eunjin Tracy, PhD (Professor, AST, University of Missouri-Columbia) — Principal investigator
First posted
Sep 23, 2026
Start date
Jan 1, 2027 (estimated)
Primary completion
Feb 28, 2028 (estimated)
Completion
May 31, 2028 (estimated)
Last update
Sep 23, 2026

Study contacts

Eunjin Tracy, PhD
Contact
eunjintracy@missouri.edu
3852454212

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion